Role of Nutritional Support in Idiopathic Male Infertility

Sponsor
NATURAmedicatrix Sàrl (Industry)
Overall Status
Unknown status
CT.gov ID
NCT03588949
Collaborator
(none)
100
1
2
19
5.3

Study Details

Study Description

Brief Summary

Approximately 100 males with idiopathic infertility and oligo- and/or astheno- and/or and/or teratozoospermia and fertile woman will take a Test dietary supplement (TDS), containing carnitine, vitamins and trace elements (active group) or carotene (control group) for 6 months (50 subjects in active and control groups). Before intake, and 2 and 4 months after the commencement of TDS, all males will have spermogram. After 6-month use of the TDS and during the 12th month of the study, couples will be screened for conception, pregnancy, and a newborn

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Dietary Supplement with L-carnitine (FertilHom)
  • Dietary Supplement: Control Dietary Supplement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Other
Official Title:
Role of Nutritional Support in Idiopathic Male Infertility: a Randomized Dietary Study
Actual Study Start Date :
Oct 1, 2018
Anticipated Primary Completion Date :
Apr 30, 2020
Anticipated Study Completion Date :
Apr 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active Dietary Supplement

Dietary Supplement with L-carnitine (FertilHom)

Dietary Supplement: Dietary Supplement with L-carnitine (FertilHom)
1 stick of the TDS (vitamins, trace elements with carnitine) will be given 1 time daily in the evening before meals for 6 months or until pregnancy, depending whatever comes first

Placebo Comparator: Control Dietary Supplement

Dietary Supplement with 50% RDA of beta-carotene

Dietary Supplement: Control Dietary Supplement
1 stick of the TDSwill be given 1 time daily in the evening before meals for 6 months or until pregnancy, depending whatever comes first

Outcome Measures

Primary Outcome Measures

  1. Rate of normalization of spermogram [4 months]

    None deviation found in spermogram

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 50 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Informed consent form signed;

  2. Age: 21-50;

  3. Idiopathic male infertility;

  4. Idiopathic oligo- and/or astheno- and/or teratozoospermia;

  5. Stated availability throughout the study period and a mobile phone

Exclusion Criteria:
  1. Allergy to any component of the dietary supplement;

  2. Known genetic, anatomical, endocrine, inflammatory or traumatic testicular cause of male infertility;

  3. Known genetic, anatomical, endocrine, inflammatory or traumatic testicular cause of female infertility;

  4. Inflammatory bowel disease;

  5. Known moderate to severe disease of any systems;

  6. Known or suspected sexually transmitted diseases;

  7. Alcohol or drug addiction of any couple counterpart as suspected by investigator;

  8. Difficulty to comprehend study requirements as judged by investigator;

  9. Use of any investigational product within the previous 3 months before entering the study;

  10. Use of any drugs that stimulate or suppress spermatogenesis within previous 3 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 MedianaStatistics Lviv Ukraine 79012

Sponsors and Collaborators

  • NATURAmedicatrix Sàrl

Investigators

  • Study Director: Marco Pietteur, NATURAmedicatrix Sarl

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NATURAmedicatrix Sàrl
ClinicalTrials.gov Identifier:
NCT03588949
Other Study ID Numbers:
  • NATURAmedicatrix-FE-0001-M
First Posted:
Jul 17, 2018
Last Update Posted:
Feb 26, 2020
Last Verified:
Aug 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 26, 2020